SPCs: a deep dive into CJEU case law

The European Supplementary Protection Certificate (SPC) Regulation incentivises pharmaceutical research and development by providing an extension to patent protection to compensate for time lost in obtaining a marketing authorisation (MA).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

CJEU hands down SPC guidance in Royalty Pharma

30 April 2020 The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.

Generics

CJEU ‘shuts door’ on SPCs for second medical uses

10 July 2020 The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

More on this story

Big Pharma

CJEU hands down SPC guidance in Royalty Pharma

30 April 2020 The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.

Generics

CJEU ‘shuts door’ on SPCs for second medical uses

10 July 2020 The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

More on this story

Big Pharma

CJEU hands down SPC guidance in Royalty Pharma

30 April 2020 The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.

Generics

CJEU ‘shuts door’ on SPCs for second medical uses

10 July 2020 The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.